Interpreting Prostate Needle Biopsies in Today’s World – Recording
If you’re new to AnCan – welcome! Please sign up to receive a Reminder/newsletter for one or more of our 5 different prostate cancer groups each month at /contact-us/ .- Early Active Surveillance
- Low/ Intermediate (treatments)
- High Risk/Recurrent/Advanced
- Locally advanced and advanced Under-60s
- Gay and Bisexual men
Take a look at the recording of our latest webinar presentation featuring guest speaker Dr. Jonathan Epstein, MD, a leader in Advanced Uropathology. Thanks to guest panelists Dr. John Antonucci, MD, Dr. Randall Jones, PhD, and Howard Wolinsky.
Reliable biopsies are critical to selecting the right treatment at all stages of prostate cancer – we’re talking needle tissue, not blood, btw. Get it wrong and you may get too much or too little treatment.
Reading pathology is part art and part science! AnCan Advisory Board Member, Dr. Jonathan Epstein is globally acknowledged to have the best eye in the genitourinary pathology world. AnCan frequently refers men to him for a 2nd opinion. His presentation will include:
- Getting the most out of a 2nd Opinion
- The relevance of cribriform, intraductal, ductal, & small cells
- Biopsy report terms, like perineural invasion
- Role of AI – artificial intelligence